NEC Surgery: Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Sponsor
NICHD Neonatal Research Network (Other)
Overall Status
Completed
CT.gov ID
NCT01223261
Collaborator
National Center for Research Resources (NCRR) (NIH)
156
17
36
9.2
0.3

Study Details

Study Description

Brief Summary

The purposes of this study were: 1) to compare mortality and postoperative morbidities in extremely low birth weight (ELBW) infants who underwent initial laparotomy or drainage for necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP); 2) to determine the ability to distinguish NEC from IP preoperatively and the importance of this distinction on outcome measures; and 3) to evaluate the association between extent of intestinal disease determined at operation and outcome measures. All ELBW infants born at participating NRN centers were screened for the presence of NEC or IP that was thought by the pediatric surgeon and neonatologist to require surgical intervention. Data were collected enrolled infants, including: intraoperative findings recorded by the surgeon and specific post-operative complications. Neurodevelopmental examinations were conducted on surviving infants at 18-22 months corrected age.

Detailed Description

Necrotizing enterocolitis (NEC) is a condition, generally affecting premature infants, in which the intestines become ischemic (lack oxygen and/or blood flow). NEC occurs in up to 5-15% of extremely low birth weight (ELBW) infants. Isolated or focal intestinal perforation (IP) is a less common condition, affecting an estimated 4% of ELBWs, in which a hole develops in the intestines leaking fluid into the abdomin. The outcomes for infants with NEC or IP are poor: 49% die and half of the surviving infants are neurodevelopmentally impaired.

Surgical options for NEC and IP include two possible procedures: peritoneal drainage, in which a tube is placed in the abdominal cavity through a small incision for fluid to drain out; or laparotomy, in which an incision is made in the abdomen and diseased intestine is removed. Infants treated with an initial drainage sometimes go on to need a laparotomy. Most surgeons now believe that a diagnosis of the intestinal perforation (IP) may actually be either true NEC or a different and distinct pathology, termed isolated intestinal perforation. The ability to distinguish these 2 conditions preoperatively, based on perinatal characteristics, physical examination findings, and findings on abdominal plain film imaging, remains unknown. If these 2 entities can be distinguished preoperatively, the intervention chosen and outcomes may be different. From the two available surgical options, tt is not known whether initial laparotomy or peritoneal drain placement is more effective for either NEC or IP.

This study was a prospective, multicenter observational study to describe the surgical outcomes (mortality, post-operative intestinal stricture, intra-abdominal abscess formation, etc.) in ELBW infants with either NEC or IP who underwent initial laparotomy or peritoneal drainage. We also evaluated the ability of surgeons to distinguish NEC and IP pre-operatively and the relevance of this distinction on outcome. Finally, an analysis of the impact of extent of intestinal involvement with NEC on outcome measures is reported.

All ELBW infants born at participating NRN centers were screened for the presence of NEC or IP that was thought by the pediatric surgeon and neonatologist to require surgical intervention. Data were collected enrolled infants, including: intraoperative findings recorded by the surgeon and specific post-operative complications.

Neurodevelopmental examinations were conducted on surviving infants at 18-22 months corrected age.

Study Design

Study Type:
Observational
Actual Enrollment :
156 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observational Study of Surgical Treatment of Necrotizing Enterocolotis or Isolated Intestinal Perforation
Study Start Date :
Mar 1, 2001
Actual Primary Completion Date :
Sep 1, 2002
Actual Study Completion Date :
Mar 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Feasibility of conducting a randomized trial [1 year]

    Ability to enroll infants in a 1-year period

Secondary Outcome Measures

  1. Document variation in current surgical practices [Until hospital discharge or 120 days of life]

  2. Prevalence of infants who would qualify for the study [Until hospital discharge or 120 days of life]

  3. Frequency of postoperative complications [Until hospital discharge or 120 days of life]

  4. Neurodevelopmental impairment [18-22 months corrected age]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 6 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infants born 401-1,000 grams at birth enrolled in the NRN Generic Database

  • Sage III NEC or isolated intestinal perforation

  • Pediatric surgeon decision to perform surgery for suspected NEC or IP

Exclusion Criteria:
  • Decision not to treat

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35233
2 Stanford University Palo Alto California United States 94304
3 University of California at San Diego San Diego California United States 92103-8774
4 Yale University New Haven Connecticut United States 06504
5 University of Miami Miami Florida United States 33136
6 Emory University Atlanta Georgia United States 30303
7 Indiana University Indianapolis Indiana United States 46202
8 Wayne State University Detroit Michigan United States 48201
9 University of Rochester Rochester New York United States 14642
10 Wake Forest University Charlotte North Carolina United States 27157
11 RTI International Durham North Carolina United States 27705
12 Duke University Durham North Carolina United States 27710
13 Cincinnati Children's Medical Center Cincinnati Ohio United States 45267
14 Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland Ohio United States 44106
15 Brown University, Women & Infants Hospital of Rhode Island Providence Rhode Island United States 02905
16 University of Texas Southwestern Medical Center at Dallas Dallas Texas United States 75235
17 University of Texas Health Science Center at Houston Houston Texas United States 77030

Sponsors and Collaborators

  • NICHD Neonatal Research Network
  • National Center for Research Resources (NCRR)

Investigators

  • Study Director: Martin L. Blakely, MD, The University of Texas Health Science Center, Houston
  • Principal Investigator: Waldemar A. Carlo, MD, University of Alabama at Birmingham
  • Principal Investigator: William Oh, MD, Brown University, Women & Infants Hospital of Rhode Island
  • Principal Investigator: Avroy A. Fanaroff, MD, Case Western Reserve University, Rainbow Babies & Children's Hospital
  • Principal Investigator: Edward F. Donovan, MD, Children's Hospital Medical Center, Cincinnati
  • Principal Investigator: Barbara J. Stoll, MD, Emory University
  • Principal Investigator: Charles R. Bauer, MD, University of Miami
  • Principal Investigator: James A. Lemons, MD, Indiana University
  • Principal Investigator: David K. Stevenson, MD, Stanford University
  • Principal Investigator: Abbot R. Laptook, MD, University of Texas
  • Principal Investigator: Seetha Shankaran, MD, Wayne State University
  • Principal Investigator: Richard A. Ehrenkranz, MD, Yale University
  • Principal Investigator: Ronald N. Goldberg, MD, Duke University
  • Principal Investigator: T. Michael O'Shea, MD MPH, Wake Forest University
  • Principal Investigator: Dale L. Phelps, MD, University of Rochester
  • Principal Investigator: Neil N. Finer, MD, University of California, San Diego
  • Principal Investigator: W. Kenneth Poole, PhD, RTI International

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01223261
Other Study ID Numbers:
  • NICHD-NRN-0027
  • U10HD034216
  • U10HD027904
  • U10HD021364
  • M01RR000080
  • U10HD027853
  • M01RR008084
  • U10HD027851
  • M01RR000039
  • U10HD021397
  • M01RR016587
  • U10HD027856
  • M01RR000750
  • U10HD027880
  • M01RR000070
  • U10HD040689
  • M01RR000633
  • U10HD021373
  • U10HD021385
  • U10HD027871
  • M01RR006022
  • U10HD040492
  • M01RR000030
  • U10HD040498
  • M01RR007122
  • U10HD040521
  • M01RR000044
  • U10HD040461
  • U10HD036790
First Posted:
Oct 18, 2010
Last Update Posted:
Mar 22, 2019
Last Verified:
Mar 1, 2019

Study Results

No Results Posted as of Mar 22, 2019